Endo International plc (ENDP) Testing Investors’ Patience Right Now


    BlackRock Fund Advisors recently announced the acquisition of new stake in Endo International plc (NASDAQ:ENDP). The institutional investor has increased its shareholding in the Healthcare company by 2.39% to 32.29 million shares with purchase of 0.75 million shares. This fresh investment now brings its stake to 14.06% valued currently at $112.36 million. In addition, The Vanguard Group, Inc. raised its holdings by 0.46 million to 27.39 million shares. And Renaissance Technologies LLC has lifted its position by 8.82% or 1.38 million shares – to 17.05 million shares.

    With over 6.41 million Endo International plc (ENDP) shares trading Friday and a closing price of $3.03 on the day, the dollar volume was approximately $19.42 million. The shares have shown a positive weekly performance of 4.48% and its price on 08/28/20 gained nearly 8.60%. Currently, there are 229.72M common shares owned by the public and among those 226.55M shares have been available to trade.

    An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 14 analysts who have offered their price forecasts for ENDP have a consensus price objective of $5.16. The analysts have set the share’s price value over the next 12 months at a high of $9.00 and a low of $2.75 should the stock experience a downside. Incidentally, analysts’ outlook for the Endo International plc stock is 2.90 for the next 12 months. The average price target is 41.28% above its last price level and an upside to the estimated low will see the stock lose -10.18% over that period. But an upside of 66.33% will see the stock hit the forecast high price target while mean target price for the stock is $5.00.

    Insiders at the company have transacted a total of 85 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 16 of these insider trades were purchases, accounting for 712,020 shares. Insider sales of the common stock occurred on 69 occasions, with total insider shares sold totaling 1,297,705 shares.

    The top 3 mutual fund holders in Endo International plc are iShares Core S&P Small Cap ETF, Miller Opportunity Trust, and Vanguard Total Stock Market Index. iShares Core S&P Small Cap ETF owns 12.76 million shares of the company’s stock, all valued at over $44.41 million. The company bought an additional 0.12 million shares recently to bring their total holdings to about 5.56% of the shares outstanding. Miller Opportunity Trust sold -2.9 million shares to see its total holdings shrink to 7.0 million shares valued at over $24.36 million and representing 3.05% of the shares outstanding. Vanguard Total Stock Market Index bought 2093.0 shares to bring its total holdings to over 6.61 million shares at a value of $23.01 million. Vanguard Total Stock Market Index now owns shares totaling to 2.88% of the shares outstanding.

    Shares of Endo International plc (NASDAQ: ENDP) opened at $2.82, up $0.03 from a prior closing price of $2.79. However, the script later closed the day at $3.03, up 8.60%. The company’s stock has a 5-day price change of 4.48% and -20.68% over the past three months. ENDP shares are trading -35.39% year to date (YTD), with the 12-month market performance up to 23.17% higher. It has a 12-month low price of $1.97 and touched a high of $7.10 over the same period. Currently, 6.41 million shares have been traded, compared to an average intraday trading volume of 5.43 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.02%, -9.29%, and -28.73% respectively.

    Institutional ownership of Endo International plc (NASDAQ: ENDP) shares accounts for 82.40% of the company’s 229.72M shares outstanding. Mutual fund holders own 40.18%, while other institutional holders and individual stakeholders account for 41.99% and 1.65% respectively.

    It has a market capitalization of $641.21M and a beta (3y monthly) value of 1.40. The earnings-per-share (ttm) stands at -$0.35. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.55% over the week and 5.78% over the month.

    Analysts forecast that Endo International plc (ENDP) will achieve an EPS of $0.11 for the current quarter, $0.4 for the next quarter and $2.08 for 2021. The lowest estimate earnings-per-share for the quarter is $0.06 while analysts give the company a high EPS estimate of $0.2. Comparatively, EPS for the current quarter was $0.6 a year ago. Earnings per share for the fiscal year are expected to increase by 62.60%, and -1.56% over the next financial year.

    If you are looking to buy this stock, then you may note that the average analyst recommendation by 14 brokerage firm advisors rate Endo International plc (ENDP) as a “Moderate Buy” at a consensus score of 2.90. Specifically, 3 Wall Street analysts polled rate the stock as a buy, while 8 of the 14 advise that investors “hold,” and 3 rated it as a “Sell.”

    Looking at the support for the ENDP, a number of firms have released research notes about the stock. Goldman stated their Sell rating for the stock in a research note on July 27, 2020, with the firm’s price target at $3. Citigroup coverage for the Endo International plc (ENDP) stock in a research note released on April 24, 2020 offered a Buy rating with a price target of $7. Piper Jaffray was of a view on January 03, 2020 that the stock is Overweight, while Morgan Stanley gave the stock Underweight rating on July 15, 2019, issuing a price target of. Citigroup on their part issued Neutral rating on June 17, 2019.


    Please enter your comment!
    Please enter your name here